Capsulomics, Inc. — Form D/A
Capsulomics, Inc. of HALETHORPE, MD, a company, filed a Form D amendment with the SEC on 2025-03-19. The offering totals $3.0M, of which $2.4M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-03-19
- Form: D/A
- Accession: 0001800623-25-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $2.4M
- Remaining: $608K
- Investors: 10
- Date of first sale: 2019-12-17
- Revenue range: Decline to Disclose
- SEC file number: 021-358725
Issuer
- Name: Capsulomics, Inc.
- CIK: 0001800623
- Entity type: Corporation
- Jurisdiction: MARYLAND
- Incorporated: 2018
- Address: 1450 S ROLLING ROAD, HALETHORPE, MD, 21227
- Phone: 8778444487
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Daniel Lunz | Director | Halethorpe, MD |
| Stephen Meltzer | Director | Halethorpe, MD |
| John Neiderhuber | Director | Halethorpe, MD |
| Daniel Lunz | Executive Officer | Halethorpe, MD |
| William Stevens | Executive Officer | Halethorpe, MD |
Other filings by this issuer (1)
More